Gerhard Fierlbeck - Concepedia

Author

Gerhard Fierlbeck

Also Known As

FG Fierlbeck, Gerhard, Fierlbeck, Gerhard, G FIERLBECK, G Fierlbeck, G. FIERLBECK, G. Fierlbeck, GERHARD FIERLBECK, Gerhard Fierlbeck

157

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

University of Tübingen Hautklinik Heidelberg University Children's Hospital Tübingen Ludwig-Maximilians-Universität München University of Lübeck

About

Gerhard Fierlbeck is an author at University of Tübingen specializing in medicine, dermatology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	33	2.1K
2	Health Sciences	5	5	275
3	Allergy	4	4	141
4	Nursing	1	1	42
5	Public Health	1	1	10

Gerhard Fierlbeck

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma Mark R. Middleton, Jean‐Jacques Grob, Neil K. Aaronson, Journal of Clinical Oncology	2000	1.3K
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial Dinesh Khanna, Christopher P. Denton, Angelika Jahreis, The Lancet RheumatologyAutoimmune DiseaseSystemic SclerodermaSubcutaneous TocilizumabSystemic Sclerosis	2016	652
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement Nicolas Hunzelmann, E. Genth, Thomas Krieg, Lara D. Veeken	2008	285
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate) Dinesh Khanna, Christopher P. Denton, Celia J. F. Lin, Annals of the Rheumatic Diseases	2017	251
Psoriasis Induced at the Injection Site of Recombinant Interferon Gamma Gerhard Fierlbeck Archives of Dermatology ImmunodeficienciesImmunologyPsoriasis InducedDermatologyImmunotherapy	1990	187
Extent and consequences of physician delay in the diagnosis of acral melanoma S Metzger, Ulf Ellwanger, Waltraud Stroebel, Melanoma Research Acral MelanomasAcral MelanomaPhysician DelayMedicineMelanoma Diagnosis	1998	129
Immunomagnetic Enrichment, Genomic Characterization, and Prognostic Impact of Circulating Melanoma Cells Anja Ulmer, Oleg Schmidt-Kittler, Jörg Fischer, Clinical Cancer Research	2004	117
CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications—results of a retrospective analysis of 117 cases Ina Kötter, İlhan Günaydın, Marion Batra, Clinical Rheumatology Autoimmune DiseaseImmunodeficienciesRetrospective AnalysisCyclosporin AAutoimmunity	2005	115
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis Pia Moinzadeh, Elisabeth Aberer, K Ahmadi-Simab, Annals of the Rheumatic Diseases	2014	100
Transarterial chemoembolization of liver metastases in patients with uveal melanoma Peter Huppert, Gerhard Fierlbeck, P. Pereira, European Journal of Radiology Surgical OncologyHepatologyMedicineMelanomaTransarterial Chemoembolization	2009	99

Page 1